ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 94 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,951 | -74.2% | 75,500 | 0.0% | 0.00% | -66.7% |
| Q2 2023 | $38,505 | -19.0% | 75,500 | 0.0% | 0.01% | -25.0% |
| Q1 2023 | $47,565 | +3.9% | 75,500 | +7.1% | 0.01% | +9.1% |
| Q4 2022 | $45,762 | -66.4% | 70,500 | -10.8% | 0.01% | -68.6% |
| Q3 2022 | $136,000 | +43.2% | 79,050 | +3.3% | 0.04% | +45.8% |
| Q2 2022 | $95,000 | +35.7% | 76,550 | +19.5% | 0.02% | +41.2% |
| Q4 2021 | $70,000 | +12.9% | 64,050 | +87.0% | 0.02% | +6.2% |
| Q3 2021 | $62,000 | -31.1% | 34,250 | 0.0% | 0.02% | -36.0% |
| Q2 2021 | $90,000 | +3.4% | 34,250 | +41.2% | 0.02% | -3.8% |
| Q1 2021 | $87,000 | +42.6% | 24,250 | 0.0% | 0.03% | +30.0% |
| Q4 2020 | $61,000 | 0.0% | 24,250 | 0.0% | 0.02% | -9.1% |
| Q3 2020 | $61,000 | -23.8% | 24,250 | 0.0% | 0.02% | -29.0% |
| Q2 2020 | $80,000 | +35.6% | 24,250 | 0.0% | 0.03% | +19.2% |
| Q1 2020 | $59,000 | -48.2% | 24,250 | 0.0% | 0.03% | -45.8% |
| Q4 2019 | $114,000 | – | 24,250 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 15,461,829 | $2,037,869 | 0.36% |
| MSD Partners, L.P. | 15,151,516 | $1,996,970 | 0.16% |
| MSD Partners, L.P. | 7,575,758 | $998,485 | 0.08% |
| MAGNOLIA CAPITAL ADVISORS LLC | 865,938 | $65,552 | 0.03% |
| Allred Capital Management, LLC | 253,000 | $33,345 | 0.02% |
| CHIRON CAPITAL MANAGEMENT, LLC | 77,023 | $10,152 | 0.01% |
| Boxer Capital, LLC | 1,100,000 | $144,980 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 569,566 | $75 | 0.01% |
| Sugarloaf Wealth Management, LLC | 75,500 | $9,951 | 0.00% |
| Owen LaRue, LLC | 11,825 | $1,559 | 0.00% |